Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Athira Pharma Inc (NQ: ATHA ) 0.4281 -0.0210 (-4.68%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Athira Pharma Inc < Previous 1 2 3 4 5 6 7 8 9 10 Next > Exela Technologies (XELA) Stock Soars After Securing $136 Million Contract June 22, 2022 Exela Technologies (XELA) stock is taking off on Wednesday after gaining a new $136 million customer contract that lasts for three years. Via InvestorPlace Athira Pharma (ATHA) Stock Plunges 65% on Disappointing Drug Trial Results June 22, 2022 Athira Pharma (ATHA) stock is plummeting on Wednesday following the outcome of a Phase 2 clinical trial of fosgonimeton. Via InvestorPlace The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral June 22, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Why Athira Pharma Stock Is Plunging June 22, 2022 Athira Pharma Inc (NASDAQ: ATHA) shares are falling Wednesday after the company announced topline results from its exploratory ACT-AD Phase 2 study of fosgonimeton in patients with mild-to-moderate... Via Benzinga Athira Pharma Shares Fall To 52-Week Low - Read Why June 22, 2022 Via Benzinga ATHIRA PHARMA INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Athira Pharma, Inc. - ATHA May 27, 2022 From Kahn Swick & Foti, LLC Via Business Wire ATHIRA ALERT: Bragar Eagel & Squire, P.C. Is Investigating Athira Pharma, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm May 20, 2022 From Bragar Eagel & Squire, P.C. Via Business Wire ATHIRA PHARMA INVESTIGATION CONTINUED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Athira Pharma, Inc. - ATHA May 05, 2022 From Kahn Swick & Foti, LLC Via Business Wire ATHIRA PHARMA INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Athira Pharma, Inc. - ATHA April 29, 2022 From Kahn Swick & Foti, LLC Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2022 May 10, 2022 Upgrades Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For April 21, 2022 April 21, 2022 Via Benzinga ATHIRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Athira Pharma, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm April 15, 2022 From Bragar Eagel & Squire, P.C. Via Business Wire The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO March 25, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Via Benzinga The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL March 24, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Earnings Scheduled For March 24, 2022 March 24, 2022 Companies Reporting Before The Bell • iHuman (NYSE:IH) is likely to report earnings for its fourth quarter. • Pioneer Muni High Inc (NYSE:MAV) is expected to... Via Benzinga Earnings Preview: Athira Pharma March 23, 2022 Athira Pharma (NASDAQ:ATHA) is set to give its latest quarterly earnings report on Thursday, 2022-03-24. Here's what investors need to know before the announcement. Analysts... Via Benzinga The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings March 20, 2022 Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment... Via Benzinga 35 Stocks Moving In Friday's Mid-Day Session October 22, 2021 Gainers Phunware, Inc. (NASDAQ: PHUN) rose 1099% to $18.35. Phunware shares jumped over 45% on Thursday, possibly in sympathy with Digital World Acquisition as traders circulated... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021 December 15, 2021 Upgrades B of A Securities upgraded the previous rating for ONE Gas Inc (NYSE: Via Benzinga Athira CEO Resigns After Data Manipulation Firestorm, But Alzheimer's Stock Pops October 22, 2021 Athira CEO Leen Kawas resigned after an investigation found she altered images. Via Investor's Business Daily Why Shares of Athira Pharma Are Climbing Today October 22, 2021 The clinical trial for its Alzheimer's drug is one step closer to completion. Via The Motley Fool The Daily Biotech Pulse: Athira CEO Resigns Over Doctored Research, Merck's Keytruda Snags First Approval For Breast Cancer In Europe, Minerva And Xilio IPOs October 22, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Athira Names Chief Operating Officer Mark Litton As Next CEO as Leen Kawas... Via Benzinga Rebuilding Connections, Fostering Growth: Synaptogenix Could Be A Beacon of Hope for Patients With Neurological Diseases October 05, 2021 Image by Gerd Altmann from Pixabay How well we think, feel and act rests in the hands of trillions of tiny connectors in our minds. Synapses play an integral role in how we... Via Benzinga NASDAQ:ATHA Long Term Investor Notice: Investigation of Potential Wrongdoing at Athira Pharma, Inc. October 01, 2021 San Diego, CA -- (SBWIRE) -- 10/01/2021 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Athira Pharma, Inc. Via SBWire Topics Intellectual Property Lawsuit Exposures Financial Intellectual Property Legal ATHIRA SHAREHOLDER NOTICE August 29, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Initial Public Offering Intellectual Property Lawsuit Exposures Financial Intellectual Property Legal ATHIRA SHAREHOLDER ALERT August 27, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Initial Public Offering Intellectual Property Lawsuit Exposures Financial Intellectual Property Legal ATHIRA DEADLINE ALERT August 25, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Initial Public Offering Intellectual Property Lawsuit Exposures Financial Intellectual Property Legal CLASS ACTION UPDATE for ATHA, OTLY and AHCO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders August 24, 2021 NEW YORK, NY / ACCESSWIRE / August 24, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies.... From Levi & Korsinsky, LLP Via AccessWire Topics Intellectual Property Lawsuit Exposures Financial Intellectual Property Legal Last Day for Shareholders to Actively Participate in Athira Pharma, Inc. (ATHA) Class Action: Bronstein, Gewirtz & Grossman, LLC August 24, 2021 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Athira Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm August 24, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal < Previous 1 2 3 4 5 6 7 8 9 10 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.